Sildenafil, a Phosphodiesterase-5 Inhibitor, Delays Gastric Emptying and Gastrointestinal Transit of Liquid in Awake Rats

Digestive Diseases and Sciences

Volumn 48, Issue 10, 2003, Pages 2064-2068

  De Rosalmeida, Mauro Cabral ^a   Saraiva, Luciana Duarte Sobreira ^a   Da Graça, José Ronaldo Vasconcelos ^a   Ivo, Bruno Barreto ^a   Da Nöbrega, Marcel Vieira ^a   Gondim, Francisco De Assis Aquino ^a   Rola, Francisco Hélio ^a   Dos Santos, Armenio Aguiar ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Gastrointestinal motility; Phosphodiesterase; Rats; Sildenafil

Indexed keywords

CYCLIC GMP; OMEPRAZOLE; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FLUID INTAKE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; LIQUID; LOWER ESOPHAGUS SPHINCTER; MALE; MEAN ARTERIAL PRESSURE; NEUROTRANSMITTER RELEASE; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION; STOMACH EMPTYING; VASCULAR SMOOTH MUSCLE; WAKEFULNESS;

ANIMALS; BLOOD PRESSURE; COLORING AGENTS; ENZYME INHIBITORS; GASTRIC EMPTYING; GASTROINTESTINAL TRANSIT; MALE; OMEPRAZOLE; PHENOLSULFONPHTHALEIN; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; RATS; RATS, WISTAR;

EID: 0242403409     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026151227729     Document Type: Article

References (34)

1. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA: Oral sildenafil in the treatment of erectile disfunction. N Engl J Med 338:1397-1404, 1998
2. Jeremy JY, Ballard AS, Naylor AM, Miller MA, Angelini GD: Effects of sildenafil, a type 5 cGMP phosphodiesterase inhibitor, and papaverine on cGMP and cAMP levels in the rabbit corpus cavernosus in vitro. Br J Urol 79:958-963, 1997
3. Chuang AT, Strauss JD, Murphy RA, Steers WD: Sildenafil, a type-5 cGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. J Urol 160:257-261, 1998
4. Gibson A: Phosphodiesterase 5 inhibitors and nitrergic transmission - from Zaprinast to Sildenafil. Eur J Pharmacol 411:1-10, 2001
5. Stark ME, Szurszewski JH: Role of nitric oxide in gastro-intestinal and hepatic function disease. Gastroenterology 103:1928-1949, 1992
6. Sanders KM, Ward SM: Nitric oxide as a mediator of non-adrenergic non-cholinergic neurotransmission. Am J Physiol 262:G379-G392, 1992
7. Du C, Murray J, Bates JN, Conklin JL: Nitric oxide: mediator of NANC hyperpolarization of opossum esophageal smooth muscle. Am J Physiol 261:G1012-G1016, 1991
8. Beavo JA: Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75:725-748, 1995
9. Zhang X, Tack J, Janssens J, Sifrim D: Effect of sildenafil, a phosphodiesterase-5 inhibitor, on oesophageal peristalsis and lower oesophageal sphincter function in cats. Neurogastroenterol Motil 13:325-331, 2001
10. Bortolotti M, Mari C, Lopilato C, La Rovere L, Miglioli M: Sildenafil inhibits gastroduodenal motility. Aliment Pharmacol Ther 15:157-161, 2001
11. Haba T, Sarna SK: Regulation of gastroduodenal empyting of solids by gastroduodenal contractions. Am J Physiol 264:G261-G271, 1993
12. Rosalmeida MC, Araújo PV, Saraiva LDS, Graça JRV, Ivo BB, Nóbrega MV, Clemente CM, Magalhães PJC, Rola FH, Santos AA: In vitro and in vivo effects of sildenafil on gut motility in rats. Neurogastroenterol Motil 14:589, 2002
13. Reynell PC, Spray GH: The simultaneous measurement of absorption and transit in the gastrointestinal tract of the rat. J Physiol 131:452-462, 1956
14. Gondim FA, Oliveira GR, Graça JRV, Gondim RBM, Alencar HMP, Dantas RP, Santos AA, Rola FH: Neural mechanisms involved in the delay of gastric emptying of liquid elicited by acute blood volume expansion in awake rats. Neurogastroenterol Motil 12:93-99, 1999
15. Gondim F de AA, Rodrigues CL, Graça JR, Camurça FD, Alencar HM, Santos AA, Rola FH: Neural mechanisms involved in the delay of gastric emptying and gastrointestinal transit of liquid after thoracic spinal cord transection in awake rats. Auton Neurosci 87:52-58, 2001
16. Dundore RL, Habeeb PG, Pratt PF, Becker LT, Clas DM, Buchholz RA: Differential hemodynamic responses to selective inhibitors of cyclic nucleotide phosphodiesterases in conscious rats. J Cardiovasc Pharmacol 19:937-944, 1992
17. Sharma RK: Study of gastric and intestinal motility in young and adult rats. Indian J Med Res 78:713-723, 1983
18. Rhee PL, Hyun JG, Lee JH, Kim YH, Son HJ, Kim JJ, Paik SW, Rhee JC, Choi KW: The effect of sildenafil on lower esophageal sphincter and body motility in normal male adults. Am J Gastroenterol 96:3251-3257, 2001
19. Tottrup A, Glavind EB, Svane D: Involvement of the L-arginine-nitric oxide pathway in internal anal sphincter relaxation. Gastroenterology. 102:409-415, 1992
20. Anand N, Paterson WG: Role of nitric oxide in esophageal peristalsis. Am J Physiol 226:G123-G131, 1994
21. Desai KM, Sessa WC, Vane JR : Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid. Nature 351:477-479, 1991
22. Russo A, Fraser R, Adachi K, Horowitz M, Boeckxstaens G: Evidence that nitric oxide mechanisms regulate small intestinal motility in humans. Gut 44:72-76, 1999
23. Maczka M, Thor P, Lorens K, Konturek SJ: Nitric oxide inhibits the myoelectric activity of the small intestine in dogs. J Physiol Pharmacol 44:31-42, 1993
24. Sarna SK, Otterson MF, Ryan RP, Cowles VE: Nitric oxide regulates migrating motor complex cycling and postprandial disruption. Am J Physiol 265:G759-G766, 1993
25. Rodriguez-Membrilla A, Marinez V, Jimenez M, Gonalons E, Vergara P: Is nitric oxide the final mediator regulating the migrating myoelectric complex cycle? Am J Physiol 268:G207-G214, 1995
26. Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM: Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 159:2164-2171, 1998
27. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ: Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 18:47-52, 1996
28. Sun WM, Doran S, Jones KL, Ooi E, Boeckxstaens G, Hebbard GS, Lingenfelser T, Morley JE, Dent J, Horowitz M: Effects of nytroglicerin on liquid gastric emptying and antropyloroduodenal motility. Am J Physiol 275:G1173-G1178, 1998
29. Allescher HD, Tougas G, Vergara P, Lu S, Daniel EE: Nitric oxide as a putative nonadrenergic noncholinergic inhibitory transmitter in the canine pylorus in vivo. Am J Physiol 262:G695-G702, 1992
30. Vobig MA: Retinal side-effects of sildenafil. Lancet 353:1442, 1999
31. Phillips BG, Kato M, Pesek CA, Winnicki M, Narkiewicz K, Davison D, Somers VK: Sympathetic activation by sildenafil. Circulation 102:3068-3073, 2000
32. Ishiguchi T, Nishioka S, Takahashi T: Inhibitory neural pathway regulating gastric emptying in rats. J Aut Nerv Syst 79:45-51, 2000
33. Goldenberger MM: Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction. Clin Ther 20:1033-1048, 1998
34. Rendell MS, Raifer J Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes a randomized controlled trial. J Am Med Assoc 281:421-426, 1999